Stanton McHardy and Hua-Yu Leo Wang) at the Center for Innovative Drug Discovery, University of Texas San Antonio for the synthesis and supply of scaled batches of 5-amino-1-methylquinolinium
Youre not alone
Maintenance Phase: Many users transition to maintenance dosing during this period, having achieved significant metabolic improvements
This oral peptide is particularly effective for individuals with: Excess visceral (abdominal) fat Metabolic syndrome or insulin resistance Age-related NAD+ decline Fat loss goals while preserving muscle mass GLP-1 users who want to offset muscle loss Its also ideal for people who: Prefer oral therapy over injections Travel frequently and need convenience Want a well-tolerated fat loss support with no stimulant effects How It Compares to Other Peptides Side Effects and Safety To date, no harmful side effects have been reported with oral 5-Amino-1MQ in either animal studies or clinical use
Catherine Sampson, Sierra Miller, Kehinde Ogunseye, and Erika Main for help with technical aspects of this study, Dr
The honest answer about what they do, what the evidence says, and how we approach them at CoLaz